Jonathan Lanfear
Directeur des opérations chez Hibercell, Inc.
Fortune : - $ au 30/04/2024
Postes actifs de Jonathan Lanfear
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Aquinnah Pharmaceuticals, Inc.
 Aquinnah Pharmaceuticals, Inc. BiotechnologyHealth Technology Aquinnah Pharmaceuticals, Inc. restores the health of people with ALS, Alzheimer?s disease and other neurodegenerative diseases. The company was founded by Glenn Larsen and Ben Wolozin in 2014 and is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | - | - |
| Lanfear Advisors LLC | Corporate Officer/Principal | - | - |
Hibercell, Inc.
 Hibercell, Inc. Miscellaneous Commercial ServicesCommercial Services Hibercell, Inc. specializes on tumor dormancy detection and therapeutics. It provides treatment for primary tumors, metastatic cancer. The company was founded by Alan Rigby, Julio Aguirre-Ghiso, and Ari Nowacek and is headquartered in New York, NY. | Directeur des opérations | 30/09/2021 | - |
Historique de carrière de Jonathan Lanfear
Anciens postes connus de Jonathan Lanfear
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| MOLECULAR TEMPLATES, INC. | Directeur/Membre du Conseil | 31/05/2018 | 11/01/2024 |
| Independent Dir/Board Member | 31/05/2018 | 11/01/2024 | |
Takeda Pharmaceuticals International, Inc.
 Takeda Pharmaceuticals International, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Takeda Pharmaceutical Co., Ltd., Takeda Pharmaceuticals International, Inc. provides management consulting for pharmaceutical businesses. The company is based in Deerfield, IL. | Corporate Officer/Principal | 01/01/2011 | 01/10/2020 |
| PFIZER, INC. | Corporate Officer/Principal | - | 01/01/2011 |
ARTham Therapeutics, Inc.
 ARTham Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Kaken Pharmaceutical Co., Ltd., ARTham Therapeutics, Inc. is a pharmaceutical company based in Yokohama, Japan. The Japanese company's mission is to deliver "medicines that matter" to improve patient health and contribute to enhanced quality of life through the development of innovative disease-modifying medicines. The company was founded by Sham Nikam, Naoto Uemura, and has been led by CEO Hiroshi Nagabukuro since 2018. ARTham Therapeutics was acquired by Kaken Pharmaceutical Co., Ltd. on December 13, 2021 for $111.95 million. | Directeur/Membre du Conseil | - | - |
Formation de Jonathan Lanfear
| University of Michigan | Graduate Degree |
| University of Washington | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 9 |
| Japon | 2 |
Opérationnelle
| Director/Board Member | 3 |
| Corporate Officer/Principal | 3 |
| Independent Dir/Board Member | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 3 |
| Commercial Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| MOLECULAR TEMPLATES, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Aquinnah Pharmaceuticals, Inc.
Aquinnah Pharmaceuticals, Inc. BiotechnologyHealth Technology Aquinnah Pharmaceuticals, Inc. restores the health of people with ALS, Alzheimer?s disease and other neurodegenerative diseases. The company was founded by Glenn Larsen and Ben Wolozin in 2014 and is headquartered in Cambridge, MA. | Health Technology |
Takeda Pharmaceuticals International, Inc.
Takeda Pharmaceuticals International, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Takeda Pharmaceutical Co., Ltd., Takeda Pharmaceuticals International, Inc. provides management consulting for pharmaceutical businesses. The company is based in Deerfield, IL. | Commercial Services |
| Lanfear Advisors LLC | |
ARTham Therapeutics, Inc.
ARTham Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Kaken Pharmaceutical Co., Ltd., ARTham Therapeutics, Inc. is a pharmaceutical company based in Yokohama, Japan. The Japanese company's mission is to deliver "medicines that matter" to improve patient health and contribute to enhanced quality of life through the development of innovative disease-modifying medicines. The company was founded by Sham Nikam, Naoto Uemura, and has been led by CEO Hiroshi Nagabukuro since 2018. ARTham Therapeutics was acquired by Kaken Pharmaceutical Co., Ltd. on December 13, 2021 for $111.95 million. | Health Technology |
Hibercell, Inc.
Hibercell, Inc. Miscellaneous Commercial ServicesCommercial Services Hibercell, Inc. specializes on tumor dormancy detection and therapeutics. It provides treatment for primary tumors, metastatic cancer. The company was founded by Alan Rigby, Julio Aguirre-Ghiso, and Ari Nowacek and is headquartered in New York, NY. | Commercial Services |
- Bourse
- Insiders
- Jonathan Lanfear
- Expérience
